ArticleJournal for immunotherapy of cancer2015

Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma.

Frederick L Locke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.